OrthoPediatrics Corp. $KIDS Shares Sold by Brown Capital Management LLC

Brown Capital Management LLC reduced its stake in OrthoPediatrics Corp. (NASDAQ:KIDS) by 30.5% during the 3rd quarter, HoldingsChannel reports. The firm owned 1,081,220 shares of the company’s stock after selling 475,484 shares during the period. Brown Capital Management LLC’s holdings in OrthoPediatrics were worth $20,035,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Los Angeles Capital Management LLC purchased a new stake in shares of OrthoPediatrics in the second quarter valued at approximately $220,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of OrthoPediatrics by 6.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,995 shares of the company’s stock worth $246,000 after purchasing an additional 645 shares during the last quarter. R Squared Ltd purchased a new stake in shares of OrthoPediatrics in the second quarter valued at $272,000. Connor Clark & Lunn Investment Management Ltd. raised its position in shares of OrthoPediatrics by 12.4% in the second quarter. Connor Clark & Lunn Investment Management Ltd. now owns 15,901 shares of the company’s stock valued at $342,000 after buying an additional 1,753 shares during the last quarter. Finally, Jane Street Group LLC acquired a new position in OrthoPediatrics in the first quarter valued at $389,000. Hedge funds and other institutional investors own 69.05% of the company’s stock.

OrthoPediatrics Price Performance

Shares of OrthoPediatrics stock opened at $17.29 on Tuesday. OrthoPediatrics Corp. has a 52 week low of $15.28 and a 52 week high of $26.40. The company has a current ratio of 7.40, a quick ratio of 3.52 and a debt-to-equity ratio of 0.28. The stock has a market cap of $433.63 million, a PE ratio of -8.87 and a beta of 1.12. The company’s 50-day moving average price is $18.06 and its two-hundred day moving average price is $18.66.

Analyst Upgrades and Downgrades

KIDS has been the subject of several research analyst reports. TD Cowen upgraded OrthoPediatrics to a “strong-buy” rating in a research note on Tuesday, January 27th. Lake Street Capital cut their target price on OrthoPediatrics from $37.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, October 10th. Weiss Ratings reiterated a “sell (e+)” rating on shares of OrthoPediatrics in a report on Thursday, January 22nd. Citigroup reissued an “outperform” rating on shares of OrthoPediatrics in a report on Friday, October 10th. Finally, Wall Street Zen raised shares of OrthoPediatrics from a “sell” rating to a “hold” rating in a report on Saturday, January 17th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, OrthoPediatrics has a consensus rating of “Moderate Buy” and a consensus price target of $23.89.

OrthoPediatrics Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.